EPS Bio Technology Corp. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 100.4 million compared to TWD 119.41 million a year ago. Revenue was TWD 100.4 million compared to TWD 119.41 million a year ago. Net income was TWD 4.95 million compared to TWD 6.46 million a year ago. Basic earnings per share from continuing operations was TWD 0.21 compared to TWD 0.27 a year ago. Diluted earnings per share from continuing operations was TWD 0.21 compared to TWD 0.27 a year ago.
For the six months, sales was TWD 213.06 million compared to TWD 207.89 million a year ago. Revenue was TWD 213.06 million compared to TWD 207.89 million a year ago. Net income was TWD 7.46 million compared to TWD 1.11 million a year ago. Basic earnings per share from continuing operations was TWD 0.31 compared to TWD 0.05 a year ago. Diluted earnings per share from continuing operations was TWD 0.31 compared to TWD 0.05 a year ago.